Beruflicher Werdegang
1998 bis 2010
Assistenzarzt, dann Facharzt, später Oberarzt in der Hautklinik, Universitätsklinikum Jena
Seit 2011
Chefarzt der Klinik für Hautkrankheiten und Allergologie am SRH Wald-Klinikum Gera
Zur Personenübersicht
Priv.-Doz. Dr. med. habil. Martin Kaatz
Facharzt für Haut- und Geschlechtskrankheiten, Dermatologie, Venerologie, Allergologie
Zusatzbezeichnungen:
Allergologie
Medikamentöse Tumortherapie
Dermatohistologie
Palliativmedizin
Berufsdermatologie
Neurodermitistrainer für Kinder und Erwachsene
Zusatzbezeichnungen:
Allergologie
Medikamentöse Tumortherapie
Dermatohistologie
Palliativmedizin
Berufsdermatologie
Neurodermitistrainer für Kinder und Erwachsene
Kontakt und Zuständigkeiten Ich bin für Sie da
So erreichen Sie mich
| Telefon | 0365 828-7701 |
| Fax | 0365 828-7702 |
| martin.kaatz@srh.de |
Hierfür bin ich zuständig
| Zentrumsleiter: | Onkologisches Zentrum |
| Zentrumsleiter: | Hautkrebszentrum |
| Zentrumsleiter: | Klinische Studien |
| Chefarzt: | Hautkrankheiten und Allergologie |
Über mich
Meine bisherigen Stationen
Weiterbildungsermächtigungen
Hier gebe ich mein Wissen weiter
Facharzt für Haut- und Geschlechtskrankheiten
ZWB Allergologie
ZWB Medikamentöse Tumortherapie
Publikationen
Für Sie veröffentlicht
Artificial Intelligence in Multiphoton Tomography
Artificial Intelligence in Multiphoton Tomography: Atopic Dermatitis Diagnosis.
Guimarães P, Batista A, Zieger M, Kaatz M, Koenig K.Sci Rep. 2020 May 14;10(1):7968. doi: 10.1038/s41598-020-64937-x.PMID: 32409755 Free PMC article.
Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma
Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG.
Knispel S, Stang A, Zimmer L, Lax H, Gutzmer R, Heinzerling L, Weishaupt C, Pföhler C, Gesierich A, Herbst R, Kaehler KC, Weide B, Berking C, Loquai C, Utikal J, Terheyden P, Kaatz M, Schlaak M, Kreuter A, Ulrich J, Mohr P, Dippel E, Livingstone E, Becker JC, Weichenthal M, Chorti E, Gronewold J, Schadendorf D, Ugurel S.J Immunother Cancer. 2020 May;8(1):e000395. doi: 10.1136/jitc-2019-000395.PMID: 32371460 Free PMC article.
Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatmen
Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172).
Schadendorf D, Ascierto PA, Haanen J, Espinosa E, Demidov L, Garbe C, Guida M, Lorigan P, Chiarion-Sileni V, Gogas H, Maio M, Fierro MT, Hoeller C, Terheyden P, Gutzmer R, Guren TK, Bafaloukos D, Rutkowski P, Plummer R, Waterston A, Kaatz M, Mandala M, Marquez-Rodas I, Muñoz-Couselo E, Dummer R, Grigoryeva E, Young TC, Nathan P.
Eur J Cancer. 2019 Nov;121:144-153. doi: 10.1016/j.ejca.2019.08.014. Epub 2019 Sep 30.PMID: 31581055 Clinical Trial.
Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study
Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172).
Nathan P, Ascierto PA, Haanen J, Espinosa E, Demidov L, Garbe C, Guida M, Lorigan P, Chiarion-Sileni V, Gogas H, Maio M, Fierro MT, Hoeller C, Terheyden P, Gutzmer R, Guren TK, Bafaloukos D, Rutkowski P, Plummer R, Waterston A, Kaatz M, Mandala M, Marquez-Rodas I, Muñoz-Couselo E, Dummer R, Grigoryeva E, Young TC, Schadendorf D.
Eur J Cancer. 2019 Sep;119:168-178. doi: 10.1016/j.ejca.2019.07.010. Epub 2019 Aug 21.PMID: 31445199 Clinical Trial.
Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node.
Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node.
Leiter U, Stadler R, Mauch C, Hohenberger W, Brockmeyer NH, Berking C, Sunderkötter C, Kaatz M, Schatton K, Lehmann P, Vogt T, Ulrich J, Herbst R, Gehring W, Simon JC, Keim U, Verver D, Martus P, Garbe C; German Dermatologic Cooperative Oncology Group.
J Clin Oncol. 2019 Nov 10;37(32):3000-3008. doi: 10.1200/JCO.18.02306. Epub 2019 Sep 26.PMID: 31557067 Clinical Trial.
l.
Circulating epithelial tumor cells as a prognostic tool for malignant melanoma.
Circulating epithelial tumor cells as a prognostic tool for malignant melanoma.
Pachmann K, Willecke-Hochmuth R, Schneider K, Kaatz M.Melanoma Res. 2018 Feb;28(1):37-43. doi: 10.1097/CMR.0000000000000407.PMID: 29076925
Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II trial (APREPRU).
Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II trial (APREPRU).
Tsianakas A, Zeidler C, Riepe C, Borowski M, Forner C, Gerss J, Metz M, Staubach P, Raap U, Kaatz M, Urban M, Luger TA, Ständer S.Acta Derm Venereol. 2019 Apr 1;99(4):379-385.
doi: 10.2340/00015555-3120.
PMID: 30653242 Free article. Clinical Trial.
Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma
Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis.
D'Angelo SP, Larkin J, Sosman JA, Lebbé C, Brady B, Neyns B, Schmidt H, Hassel JC, Hodi FS, Lorigan P, Savage KJ, Miller WH Jr, Mohr P, Marquez-Rodas I, Charles J, Kaatz M, Sznol M, Weber JS, Shoushtari AN, Ruisi M, Jiang J, Wolchok JD.J Clin Oncol. 2017 Jan 10;35(2):226-235. doi: 10.1200/JCO.2016.67.9258. Epub 2016 Nov 7.PMID: 28056206 Free PMC article.
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases.
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases.
Faries MB, Mozzillo N, Kashani-Sabet M, Thompson JF, Kelley MC, DeConti RC, Lee JE, Huth JF, Wagner J, Dalgleish A, Pertschuk D, Nardo C, Stern S, Elashoff R, Gammon G, Morton DL; MMAIT-IV Clinical Trial Group.Ann Surg Oncol. 2017 Dec;24(13):3991-4000. doi: 10.1245/s10434-017-6072-3. Epub 2017 Oct 10.PMID: 29019177 Clinical Trial.
Low levels of classical BSE infectivity in rendered fat tissue.
Low levels of classical BSE infectivity in rendered fat tissue.
Fast C, Keller M, Kaatz M, Ziegler U, Groschup MH.Vet Res. 2018 Dec 20;49(1):122. doi: 10.1186/s13567-018-0618-7.PMID: 30572960 Free PMC article.
Als Melanommetastase diagnostizierter Riesenzelltumor
Als Melanommetastase diagnostizierter Riesenzelltumor: Sondengeführte Operation einer mittels PET/CT identifizierten Läsion.
Drescher R, Marintschev I, Kaatz M, Kuehnel C, Freesmeyer M.J Dtsch Dermatol Ges. 2017 Aug;15(8):833-836. doi: 10.1111/ddg.13269_g.PMID: 28763586 No abstract available.
Giant cell tumor mimicking melanoma metastasis
Giant cell tumor mimicking melanoma metastasis: radioguided surgery of a lesion detected on PET/CT.
Drescher R, Marintschev I, Kaatz M, Kuehnel C, Freesmeyer M.J Dtsch Dermatol Ges. 2017 Aug;15(8):833-835. doi: 10.1111/ddg.13269. Epub 2017 Jun 14.PMID: 28613000
Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial
Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial.
Ugurel S, Loquai C, Terheyden P, Schadendorf D, Richtig E, Utikal J, Gutzmer R, Rass K, Sunderkötter C, Stein A, Fluck M, Kaatz M, Trefzer U, Kähler K, Stadler R, Berking C, Höller C, Kerschke L, Edler L, Kopp-Schneider A, Becker JC.Oncotarget. 2017 Jun 27;8(44):76029-76043. doi: 10.18632/oncotarget.18635. eCollection 2017 Sep 29.PMID: 29100289 Free PMC article.
Treatment patterns and outcomes for patients with locally advanced basal cell carcinoma before availability of Hedgehog pathway inhibitors
Treatment patterns and outcomes for patients with locally advanced basal cell carcinoma before availability of Hedgehog pathway inhibitors: a retrospective chart review.
Lear JT, Basset-Seguin N, Kaatz M, Jouary T, Mortier L, Fabrizio T, Herd R, Leverkus M, Revil C, Page DR, Grob JJ.Eur J Dermatol. 2017 Aug 1;27(4):386-392. doi: 10.1684/ejd.2017.3031.PMID: 28862133
Interactions from complementary and alternative medicine in patients with melanoma.
Interactions from complementary and alternative medicine in patients with melanoma.
Loquai C, Schmidtmann I, Garzarolli M, Kaatz M, Kähler KC, Kurschat P, Meiss F, Micke O, Muecke R, Muenstedt K, Nashan D, Stein A, Stoll C, Dechent D, Huebner J.Melanoma Res. 2017 Jun;27(3):238-242. doi: 10.1097/CMR.0000000000000339.PMID: 28252553
Use of complementary and alternative medicine
Use of complementary and alternative medicine: A multicenter cross-sectional study in 1089 melanoma patients.
Loquai C, Dechent D, Garzarolli M, Kaatz M, Kaehler KC, Kurschat P, Meiss F, Micke O, Muecke R, Muenstedt K, Stein A, Nashan D, Stoll C, Schmidtmann I, Huebner J.Eur J Cancer. 2017 Jan;71:70-79. doi: 10.1016/j.ejca.2016.10.029. Epub 2016 Dec 14.PMID: 27984769 Clinical Trial.
Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma
Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.
Leiter U, Stadler R, Mauch C, Hohenberger W, Brockmeyer N, Berking C, Sunderkötter C, Kaatz M, Schulte KW, Lehmann P, Vogt T, Ulrich J, Herbst R, Gehring W, Simon JC, Keim U, Martus P, Garbe C; German Dermatologic Cooperative Oncology Group (DeCOG).Lancet Oncol. 2016 Jun;17(6):757-767. doi: 10.1016/S1470-2045(16)00141-8. Epub 2016 May 5.PMID: 27161539 Clinical Trial.
Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanoma.
Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanoma.
Loquai C, Dechent D, Garzarolli M, Kaatz M, Kaehler KC, Kurschat P, Meiss F, Stein A, Nashan D, Micke O, Muecke R, Muenstedt K, Stoll C, Schmidtmann I, Huebner J.Med Oncol. 2016 May;33(5):52. doi: 10.1007/s12032-016-0764-6. Epub 2016 Apr 18.PMID: 27090799
Genetic, histochemical and biochemical studies on goat TSE cases from Cyprus.
Genetic, histochemical and biochemical studies on goat TSE cases from Cyprus.
Niedermeyer S, Eiden M, Toumazos P, Papasavva-Stylianou P, Ioannou I, Sklaviadis T, Panagiotidis C, Langeveld J, Bossers A, Kuczius T, Kaatz M, Groschup MH, Fast C.Vet Res. 2016 Oct 6;47(1):99. doi: 10.1186/s13567-016-0379-0.PMID: 27716411 Free PMC article.
Retrospective chart analysis of incidental findings detected by (18) F-fluorodeoxyglucose-PET/CT in patients with cutaneous malignant melanoma.
Retrospective chart analysis of incidental findings detected by (18) F-fluorodeoxyglucose-PET/CT in patients with cutaneous malignant melanoma.
Conrad F, Winkens T, Kaatz M, Goetze S, Freesmeyer M.J Dtsch Dermatol Ges. 2016 Aug;14(8):807-16. doi: 10.1111/ddg.12924.PMID: 27509416
Retrospektive Analyse von Zufallsbefunden, die bei Patienten mit kutanem malignen Malignom durch (18) F-Fluordeoxyglucose-PET/CT erhoben wurden.
Retrospektive Analyse von Zufallsbefunden, die bei Patienten mit kutanem malignen Malignom durch (18) F-Fluordeoxyglucose-PET/CT erhoben wurden.
Conrad F, Winkens T, Kaatz M, Goetze S, Freesmeyer M.J Dtsch Dermatol Ges. 2016 Aug;14(8):807-17. doi: 10.1111/ddg.12924_g.PMID: 27509417
The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT)
The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma.
Dummer R, Guminski A, Gutzmer R, Dirix L, Lewis KD, Combemale P, Herd RM, Kaatz M, Loquai C, Stratigos AJ, Schulze HJ, Plummer R, Gogov S, Pallaud C, Yi T, Mone M, Chang AL, Cornélis F, Kudchadkar R, Trefzer U, Lear JT, Sellami D, Migden MR.J Am Acad Dermatol. 2016 Jul;75(1):113-125.e5. doi: 10.1016/j.jaad.2016.02.1226. Epub 2016 Apr 7.PMID: 27067394 Clinical Trial.
Translation of two-photon microscopy to the clinic
Translation of two-photon microscopy to the clinic: multimodal multiphoton CARS tomography of in vivo human skin.
König K, Breunig HG, Batista A, Schindele A, Zieger M, Kaatz M.J Biomed Opt. 2020 Jan;25(1):1-12. doi: 10.1117/1.JBO.25.1.014515.PMID: 32003191 Free PMC article.
Neue optische Untersuchungsverfahren für die Diagnostik von Hautkrankheiten
Sies K, Winkler JK, Zieger M, Kaatz M, Haenssle HA. Neue optische Untersuchungsverfahren für die Diagnostik von Hautkrankheiten [New optical examination procedures for the diagnosis of skin diseases]. Hautarzt. 2020 Feb;71(2):101-108. German. doi: 10.1007/s00105-019-04531-z. PMID: 31965207.
Multiphotonic staging of chronic wounds and evaluation of sterile, optical transparent bacterial nanocellulose covering
Springer S, Zieger M, Hipler UC, Lademann J, Albrecht V, Bueckle R, Meß C, Kaatz M, Huck V. Multiphotonic staging of chronic wounds and evaluation of sterile, optical transparent bacterial nanocellulose covering: A diagnostic window into human skin. Skin Res Technol. 2019 Jan;25(1):68-78. doi: 10.1111/srt.12597. Epub 2018 Jun 20. PMID: 29923636.
Non-invasive evaluation of human mucosal structures by multiphoton laser scanning tomography in vitro
Springer S, Zieger M, Hipler UC, König K, Lademann J, Kaatz M, Koehler MJ. Non-invasive evaluation of human mucosal structures by multiphoton laser scanning tomography in vitro. Skin Res Technol. 2018 Aug;24(3):445-449. doi: 10.1111/srt.12451. Epub 2018 Feb 6. PMID: 29405439.
Examination of wound healing after curettage by multiphoton tomography of human skin in vivo
Springer S, Zieger M, Böttcher A, Lademann J, Kaatz M. Examination of wound healing after curettage by multiphoton tomography of human skin in vivo. Skin Res Technol. 2017 Nov;23(4):452-458. doi: 10.1111/srt.12355. Epub 2017 Mar 7. PMID: 28271554.
Epidermal changes during UVB phototherapy assessed by multiphoton laser tomography.
Koehler MJ, Kellner K, Kaatz M, Hipler UC. Epidermal changes during UVB phototherapy assessed by multiphoton laser tomography. Skin Res Technol. 2016 Nov;22(4):437-442. doi: 10.1111/srt.12284. Epub 2016 Feb 7. PMID: 26853735.
Messverfahren der Hautalterung
Zieger M, Kaatz M. Messverfahren der Hautalterung [Methods for measuring skin aging]. Hautarzt. 2016 Feb;67(2):117-24. German. doi: 10.1007/s00105-015-3752-4. PMID: 26746403.
Multiphotonentomographie
Zieger M, Springer S, Koehler MJ, Kaatz M. Multiphotonentomographie [Multiphoton tomography]. Hautarzt. 2015 Jul;66(7):511-21. German. doi: 10.1007/s00105-015-3626-9. PMID: 25943693.
Acute UVB-induced epidermal changes assessed by multiphoton laser tomography.
Koehler MJ, Kellner K, Hipler UC, Kaatz M. Acute UVB-induced epidermal changes assessed by multiphoton laser tomography. Skin Res Technol. 2015 May;21(2):137-43. doi: 10.1111/srt.12168. Epub 2014 Jul 26. PMID: 25066913.
Atypical fibroxanthoma
Wollina U, Schönlebe J, Ziemer M, Friedling F, Koch A, Haroske G, Kaatz M, Simon JC. Atypical fibroxanthoma: a series of 56 tumors and an unexplained uneven distribution of cases in southeast Germany. Head Neck. 2015 Jun;37(6):829-34. doi: 10.1002/hed.23673. Epub 2014 Jun 20. PMID: 24946737.
Positron emission tomography/ultrasound fusion technique in patients with malignant melanoma
Freesmeyer M, Elsner P, Goetze S, Kaatz M, Winkens T. Positron emission tomography/ultrasound fusion technique in patients with malignant melanoma. J Med Imaging Radiat Oncol. 2015 Jun;59(3):320-5. doi: 10.1111/1754-9485.12280. Epub 2015 Feb 23. PMID: 25707688.
Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT)
Migden MR, Guminski A, Gutzmer R, Dirix L, Lewis KD, Combemale P, Herd RM, Kudchadkar R, Trefzer U, Gogov S, Pallaud C, Yi T, Mone M, Kaatz M, Loquai C, Stratigos AJ, Schulze HJ, Plummer R, Chang AL, Cornélis F, Lear JT, Sellami D, Dummer R. Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial. Lancet Oncol. 2015 Jun;16(6):716-28. doi: 10.1016/S1470-2045(15)70100-2. Epub 2015 May 14. PMID: 25981810.